Postpartum thyroiditis screening: Difference between revisions
Jump to navigation
Jump to search
Sunny Kumar (talk | contribs) |
Sunny Kumar (talk | contribs) |
||
| Line 17: | Line 17: | ||
*There is insufficient evidence to recommend routine screening for PPT, | *There is insufficient evidence to recommend routine screening for PPT, | ||
*According to the Endocrinology and Metabolism Clinics of North America screening for postpartum thyroiditis by measuring anti-TPO antibodies should be limited to every high risk pregnant women with: | *According to the Endocrinology and Metabolism Clinics of North America<ref name="pmid10874538">{{cite journal| author=Stagnaro-Green A| title=Recognizing, understanding, and treating postpartum thyroiditis. | journal=Endocrinol Metab Clin North Am | year= 2000 | volume= 29 | issue= 2 | pages= 417-30, ix | pmid=10874538 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10874538 }} </ref> screening for postpartum thyroiditis by measuring anti-TPO antibodies should be limited to every high risk pregnant women with: | ||
*Type 1 DM | *Type 1 DM | ||
*History of postpartum thyroiditis | *History of postpartum thyroiditis | ||
*According to the American Journal of Obstetrics and Gynecology screening for postpartum thyroiditis by measuring anti-TPO antibodies is recommended every pregnant women. | *According to the American Journal of Obstetrics and Gynecology screening for postpartum thyroiditis by measuring anti-TPO antibodies is recommended every pregnant women.<ref name="pmid3394739">{{cite journal| author=Hayslip CC, Fein HG, O'Donnell VM, Friedman DS, Klein TA, Smallridge RC| title=The value of serum antimicrosomal antibody testing in screening for symptomatic postpartum thyroid dysfunction. | journal=Am J Obstet Gynecol | year= 1988 | volume= 159 | issue= 1 | pages= 203-9 | pmid=3394739 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3394739 }} </ref> | ||
==References== | ==References== | ||
Revision as of 00:46, 30 September 2017
|
Postpartum thyroiditis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Postpartum thyroiditis screening On the Web |
|
American Roentgen Ray Society Images of Postpartum thyroiditis screening |
|
Risk calculators and risk factors for Postpartum thyroiditis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
Screening
- There is insufficient evidence to recommend routine screening for PPT,
- According to the Endocrinology and Metabolism Clinics of North America[1] screening for postpartum thyroiditis by measuring anti-TPO antibodies should be limited to every high risk pregnant women with:
- Type 1 DM
- History of postpartum thyroiditis
- According to the American Journal of Obstetrics and Gynecology screening for postpartum thyroiditis by measuring anti-TPO antibodies is recommended every pregnant women.[2]
References
- ↑ Stagnaro-Green A (2000). "Recognizing, understanding, and treating postpartum thyroiditis". Endocrinol Metab Clin North Am. 29 (2): 417–30, ix. PMID 10874538.
- ↑ Hayslip CC, Fein HG, O'Donnell VM, Friedman DS, Klein TA, Smallridge RC (1988). "The value of serum antimicrosomal antibody testing in screening for symptomatic postpartum thyroid dysfunction". Am J Obstet Gynecol. 159 (1): 203–9. PMID 3394739.